Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Norman

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|March 8, 1986
Hygiene in hospital kitchensA R Norman
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Single agent infusional 5-fluorouracil is not effective second-line therapy after raltitrexed (Tomudex) in advanced colorectal cancerD C Farrugia, A R Norman, D Cunningham
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
In regard to Padula et al., normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. IJROBP 2002;52: 439-443D P Dearnaley, A R Norman, M Shahidi
Medical and Pediatric Oncology|March 1, 1996
Paediatric tumours in the adult population: the experience of the Royal Marsden Hospital 1974-1990A M Moody, A R Norman, D Tait
The Journal of Urology|June 24, 1999
Re: Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study considerationD P Dearnaley, A R Norman, M Shahidi
The British Journal of Surgery|January 1, 1993
Timing of surgery for breast cancer in relation to the menstrual cycle and survival of premenopausal womenB Nathan, T Bates, R Anbazhagan, et al.
European Journal of Cancer Care|June 26, 2007
Elevated C-reactive protein levels are not a feature of uncomplicated radiation-induced bowel injuryU Khalid, A R Norman, H J N Andreyev
Lancet (London, England)|February 4, 1995
Survival after systemic therapy for metastatic colorectal cancerD Cunningham, M E Hill, M Watson, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?H J Andreyev, A R Norman, J Oates, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penisR Sarin, A R Norman, G G Steel, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|March 8, 1986
Hygiene in hospital kitchensA R Norman
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Single agent infusional 5-fluorouracil is not effective second-line therapy after raltitrexed (Tomudex) in advanced colorectal cancerD C Farrugia, A R Norman, D Cunningham
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
In regard to Padula et al., normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. IJROBP 2002;52: 439-443D P Dearnaley, A R Norman, M Shahidi
Medical and Pediatric Oncology|March 1, 1996
Paediatric tumours in the adult population: the experience of the Royal Marsden Hospital 1974-1990A M Moody, A R Norman, D Tait
The Journal of Urology|June 24, 1999
Re: Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study considerationD P Dearnaley, A R Norman, M Shahidi
The British Journal of Surgery|January 1, 1993
Timing of surgery for breast cancer in relation to the menstrual cycle and survival of premenopausal womenB Nathan, T Bates, R Anbazhagan, et al.
European Journal of Cancer Care|June 26, 2007
Elevated C-reactive protein levels are not a feature of uncomplicated radiation-induced bowel injuryU Khalid, A R Norman, H J N Andreyev
Lancet (London, England)|February 4, 1995
Survival after systemic therapy for metastatic colorectal cancerD Cunningham, M E Hill, M Watson, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?H J Andreyev, A R Norman, J Oates, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penisR Sarin, A R Norman, G G Steel, et al.
Pageof 8